Company intelligence / Profile preview

HAPILA

Gera, Thuringia, Germany

Ownership: Private
Employees: ~50
Development stage: Other

Overview

HAPILA is a specialized Contract Development and Manufacturing Organization (CDMO) based in Germany that focuses on the development and production of active pharmaceutical ingredients (APIs). The company provides a comprehensive suite of services ranging from chemical process development and scale-up to GMP-compliant manufacturing for clinical trials and commercial supply. HAPILA is particularly recognized for its expertise in handling high-potency APIs (HPAPIs) and complex small molecules. Their service portfolio also includes analytical development, stability testing, and regulatory support to facilitate the transition of drug candidates from the laboratory to the market.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on HAPILA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HAPILA.

Explore the full profile